Skip to main content

Kraig Biocraft Laboratories, Inc.

KBLB
Exchange
OTC
Industry
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
SEC CIK
0001413119

No open-market purchases or sales by Kraig Biocraft Laboratories, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Kraig Biocraft Laboratories, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of KBLB: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders411−2
Shares181.0K10.0K100.0K−71.0K (−41.5%)
Value$10.8K$1.00K$4.61K−$5.24K (−53.2%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (0)

Institutions that held Kraig Biocraft Laboratories, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

None.

Sold out (2)

Institutions that held Kraig Biocraft Laboratories, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of KBLB in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Fisher Asset Management, LLC70,000$4.00K
Captrust Financial Advisors1,000$0

Not filed for Q3 2022 yet (1)

Institutions that held Kraig Biocraft Laboratories, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KBLB in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
HighPoint Advisor Group LLC10,000$1.00K